Cargando…
Consensus recommendations for the diagnosis and treatment of acquired hemophilia A
BACKGROUND: Acquired hemophilia A (AHA) is a rare bleeding disorder caused by an autoantibody to coagulation factor (F) VIII. It is characterized by soft tissue bleeding in patients without a personal or family history of bleeding. Bleeding is variable, ranging from acute, life-threatening hemorrhag...
Autores principales: | Collins, Peter, Baudo, Francesco, Huth-Kühne, Angela, Ingerslev, Jørgen, Kessler, Craig M, Castellano, Maria E Mingot, Shima, Midori, St-Louis, Jean, Lévesque, Hervé |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896368/ https://www.ncbi.nlm.nih.gov/pubmed/20529258 http://dx.doi.org/10.1186/1756-0500-3-161 |
Ejemplares similares
-
International recommendations on the diagnosis and treatment of acquired hemophilia A
por: Tiede, Andreas, et al.
Publicado: (2020) -
Characterization of anti-factor VIII antibody in a patient with acquired hemophilia A
por: Oh, Jisu, et al.
Publicado: (2013) -
Acquired Hemophilia
por: Özsoylu, Şinasi
Publicado: (2014) -
Use of recombinant activated factor VII for acute bleeding episodes in acquired hemophilia: final analysis from the Hemostasis and Thrombosis Research Society Registry acquired hemophilia study
por: Ma, Alice D., et al.
Publicado: (2016) -
Bispecific Antibodies and Advances in Non–Gene Therapy Options in Hemophilia
por: Shima, Midori
Publicado: (2020)